Novo Nordisk A/S Diabetes Drug Liraglutide Helped Obese Lose More Weight Than Roche Holding AG’s Xenical

Bloomberg -- Novo Nordisk A/S’s diabetes drug liraglutide helped overweight, healthy volunteers lose significantly more weight and cut their blood pressure more than Roche Holding AG’s obesity treatment Xenical, a study found.